<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2334">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04384042</url>
  </required_header>
  <id_info>
    <org_study_id>MCO-002</org_study_id>
    <nct_id>NCT04384042</nct_id>
  </id_info>
  <brief_title>Malaysian COVID-19 Anosmia Study (Phase 2) - A Nationwide Multicentre Case-Control Study</brief_title>
  <official_title>Olfactory and Gustatory Disturbances as a Clinical Presentation of Coronavirus Disease 2019 (COVID-19) Infection in Malaysia - A Nationwide Multicentre Case-Control Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Sultanah Bahiyah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Tuanku Fauziah, Kangar, Perlis</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sultanah Maliha, Langkawi, Kedah</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Penang Hospital, Malaysia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Raja Permaisuri Bainun</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sungai Buloh, Selangor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuala Lumpur General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Tuanku Jaafar, Seremban, Negeri Sembilan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Melaka, Melaka</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sultan Ismail, Johor Bahru, Johor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Permai, Johor Bahru, Johor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sultanah Aminah Johor Bahru</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Enche Besar Hajjah Khalsom, Kluang, Johor</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Raja Perempuan Zainab II, Kota Bahru, Kelantan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Sultanah Nur Zahirah, Kuala Terengganu, Terengganu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Tengku Ampuan Afzan, Kuantan, Pahang</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sarawak General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Queen Elizabeth, Malaysia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Sultanah Bahiyah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Malaysian COVID-19 Anosmia Study is a nationwide multicentre observational study to
      investigate the prevalence and characteristics of olfactory and gustatory/taste disturbances
      in COVID-19 infection in Malaysia, and to evaluate the predictive value of screening for
      these symptoms in COVID-19 infection.

      This study consists of two phases: the first phase is a cross-sectional study and the second
      phase is a case-control study. The case-control study is described here (the cross-sectional
      study is described in a separate ClinicalTrials.gov record).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The world is currently in the midst of the Coronavirus 2019 (COVID-19) pandemic that is
      caused by a novel coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
      According to published cohort studies on COVID-29 infected patients, the most prevalent
      symptoms consist of fever, dry cough, dyspnoea, sputum production, myalgia, arthralgia,
      headache, diarrhoea, and sore throat. Recently, there have been concerns of significant viral
      transmission through asymptomatic, pre-symptomatic or even mildly symptomatic patients.

      There is increasing anecdotal evidence from patients and healthcare professionals
      highlighting isolated loss of sense of smell (anosmia) and taste disturbances (dysgeusia) as
      atypical symptoms of COVID-19 infection in otherwise asymptomatic patients. In parallel,
      expert statements from the British Association of Otorhinolaryngology-Head &amp; Neck Surgery
      (ENT UK), British Rhinological Society, and the American Association of Otolaryngology-Head &amp;
      Neck Surgery (AAO-HNS) have suggested that olfactory and taste disturbances could be a
      clinical feature of COVID-19 infection.

      Rapidly emerging evidence from Europe, the United Kingdom and the United States have found
      olfactory and taste disturbances to be highly prevalent in patients diagnosed with COVID-19.
      In contrast, there is currently limited evidence from Asia on the prevalence of these
      symptoms in COVID-19 infection. Additionally, there is also limited evidence on the
      predictive value of screening for olfactory and taste disturbance in COVID-19 patients with
      subclinical symptoms.

      The aim of this case-control study is to study the predictive value of screening for
      olfactory and taste disturbance in patients with COVID-19 infection in Malaysia. The cases
      will be selected from the cohort of COVID-19 positive patients recruited from participating
      Malaysian Ministry of Health-designated COVID-19 treating hospitals across the country (from
      Phase 1 of the Malaysian COVID-19 Anosmia Study). Controls will be recruited from healthy
      volunteers who will will answer the an online questionnaire to evaluate and characterise
      their olfactory and taste symptoms. This is the same questionnaire that is answered by the
      COVID-19 patients in case cohort.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2020</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Presence or absence of olfactory and taste disturbances in study participants</measure>
    <time_frame>2 weeks prior to answering questionnaire/ prior to diagnosis of COVID-19 infection</time_frame>
    <description>In the patient-reported online questionnaire, subjects will be asked regarding whether they experienced symptoms of olfactory and/or taste disturbances</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adjusted odds ratio of olfactory &amp; taste disturbances in COVID-19 infection</measure>
    <time_frame>2 weeks prior to answering questionnaire/ prior to diagnosis of COVID-19 infection</time_frame>
    <description>The relationship between case &amp; control status and each exposure variable will be estimated by odds ratios and their 95% confidence intervals using conditional logistic regression models.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical manifestations of study participants</measure>
    <time_frame>2 weeks prior to answering questionnaire/ prior to diagnosis of COVID-19 infection</time_frame>
    <description>In the patient-reported online questionnaire, subjects will be asked regarding other symptoms they experienced when they were diagnosed with COVID-19/within the past 2 weeks of answering the questionnaire (e.g. headache, nasal congestion, fever, chills, cough, dyspnoea, gastrointestinal symptoms, eye &amp; ear symptoms)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other pre-existing health conditions</measure>
    <time_frame>Baseline</time_frame>
    <description>In the patient-reported online questionnaire, subjects will be asked regarding their pre-existing health conditions (for example, obesity, diabetes, hypertension, cardiac conditions, previous head trauma, chronic rhinosinusitis, etc.)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive predictive value (PPV) of olfactory and taste disturbances in predicting diagnosis of COVID-19 infection</measure>
    <time_frame>Baseline</time_frame>
    <description>PPV reflects the probability that the presence of olfactory and taste disturbances will have a positive diagnosis of COVID-19. This is derived from dividing the number of patients with olfactory &amp; taste disturbances with COVID-19 infection over the total number of patients with olfactory and taste disturbances, and multiplying by 100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Negative predictive value (NPV) of olfactory and taste disturbances in predicting absence of COVID-19 infection</measure>
    <time_frame>Baseline</time_frame>
    <description>NPV reflects the probability that the absence of olfactory and taste disturbances will have a negative diagnosis of COVID-19. This is derived from dividing the number of patients without olfactory &amp; taste disturbances and without COVID-19 infection over the total number of patients with no olfactory and taste disturbances, and multiplying by 100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sensitivity of olfactory and taste disturbances in predicting COVID-19 infection</measure>
    <time_frame>Baseline</time_frame>
    <description>The percentage of true positives, i.e. the proportion of patients with olfactory and taste disorders with COVID-19 infection. This can be calculated by dividing the number of subjects with olfactory &amp; taste disturbances who have COVID-19 infection with the number of patients with olfactory &amp; taste disturbances, and multiplying by 100%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specificity of olfactory and taste disturbances in predicting COVID-19 infection</measure>
    <time_frame>Baseline</time_frame>
    <description>The percentage of true negatives, i.e. the proportion of patients without olfactory and taste disorders who do not have COVID-19 infection. This can be calculated by dividing the number of subjects without olfactory &amp; taste disturbances who do not have COVID-19 infection with the number of patients without olfactory &amp; taste disturbances, and multiplying by 100%</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>SARS-CoV Infection</condition>
  <condition>COVID-19</condition>
  <condition>Anosmia</condition>
  <condition>Dysgeusia</condition>
  <arm_group>
    <arm_group_label>Malaysian COVID-19 Cohort (Cases)</arm_group_label>
    <description>A cohort of COVID-19 positive patients will be recruited from participating Malaysian Ministry of Health-designated COVID-19 treating hospitals across the country.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Volunteers (Controls)</arm_group_label>
    <description>A cohort of age and sex-matched healthy volunteers will be recruited from participating Malaysian Ministry of Health-designated COVID-19 treating hospitals across the country.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient-Reported Online Questionnaire on Olfactory &amp; Taste Disturbances</intervention_name>
    <description>This is an online patient-reported questionnaire that examines the presence or absence of olfactory and taste disturbances, the onset of olfactory and taste disturbances in relation to other COVID-19 symptoms, and the temporal evolution of the severity of olfactory and taste disturbances. The occurrence of ear symptoms in COVID-19 infection will also be evaluated in this questionnaire as a secondary outcome. The questionnaire will also have questions relating to the patient's underlying health conditions, risk factors for COVID-19 infection, and demographics.</description>
    <arm_group_label>Healthy Volunteers (Controls)</arm_group_label>
    <arm_group_label>Malaysian COVID-19 Cohort (Cases)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This study population will draw subjects from the cohort in Phase 1 of the Malaysian
        COVID-19 Anosmia Study (Nationwide Multicentre Cross-Sectional Study) as cases. These cases
        will comprise adult patients with laboratory-confirmed COVID-19 infection from
        participating Malaysian hospital sites in this study, since the arrival of COVID-19
        infection in Malaysia (January 2020) until present time.

        The control subjects will be age and sex-matched healthy volunteers recruited from
        participating hospital sites in this study.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age at least 18 years old

          2. For Cases: Laboratory confirmed COVID-19 infection [Reverse Transcription Polymerase
             Chain Reaction (RT-PCR)]

          3. Patients clinically able to answer the questionnaire

        Exclusion Criteria:

          1. Patients with olfactory or taste/gustatory disorders before the COVID-19 epidemic

          2. For Cases: Patients without a laboratory-confirmed COVID-19 diagnosis

          3. For Cases: Patients in intensive care unit at the time of study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Siti Sabzah Mohd Hashim, MD MS</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Sultanah Bahiyah</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Siti Sabzah Mohd Hashim, MD MS</last_name>
    <phone>+604 740 7335</phone>
    <email>dr_ctsabzah@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shen-Han Lee, MB PhD MRCS</last_name>
    <phone>+6016 474 0088</phone>
    <email>shen-han.lee@cantab.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Sultanah Aminah</name>
      <address>
        <city>Johor Bahru</city>
        <state>Johor</state>
        <zip>80100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Jothi Shanmuganathan, MBBS MMed</last_name>
    </contact>
    <investigator>
      <last_name>Jothi Shanmuganathan, MBBS MMed</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Masliza Zaid, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sultan Ismail</name>
      <address>
        <city>Johor Bahru</city>
        <state>Johor</state>
        <zip>81100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Tengku Mohamed Izam Tengku Kamalden, MS FRCS</last_name>
    </contact>
    <investigator>
      <last_name>Tengku Mohamed Izam Tengku Kamalden, MS FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Permai</name>
      <address>
        <city>Johor Bahru</city>
        <state>Johor</state>
        <zip>81200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Tengku Mohamed Izam Tengku Kamalden, MS FRCS</last_name>
    </contact>
    <investigator>
      <last_name>Tengku Mohamed Izam Tengku Kamalden, MS FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Enche' Besar Hajjah Khalsom</name>
      <address>
        <city>Kluang</city>
        <state>Johor</state>
        <zip>86000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Jothi Shanmuganathan, MBBS MMed</last_name>
    </contact>
    <investigator>
      <last_name>Jothi Shanmuganathan, MBBS MMed</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Masliza Zaid, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sultanah Bahiyah</name>
      <address>
        <city>Alor Setar</city>
        <state>Kedah</state>
        <zip>05400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Siti Sabzah Mohd Hashim, MD MS</last_name>
    </contact>
    <contact_backup>
      <last_name>Shen-Han Lee, MB PhD MRCS</last_name>
    </contact_backup>
    <investigator>
      <last_name>Siti Sabzah Mohd Hashim, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Norzi Gazali, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ida Sadja'ah Sachlin, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhi Xiang Yeoh, MBBS MS MRCS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shen-Han Lee, MB PhD MRCS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lee Lee Low, MD MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sharifah Baizura Syed Alwi, MD MRCPI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Shahrul Aiman Soelar, B Ind Stats</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ibtisam Ismail, BSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sultanah Maliha</name>
      <address>
        <city>Langkawi</city>
        <state>Kedah</state>
        <zip>07000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Siti Sabzah Hashim, MD MS</last_name>
    </contact>
    <investigator>
      <last_name>Siti Sabzah Mohd Hashim, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Raja Perempuan Zainab II</name>
      <address>
        <city>Kota Bharu</city>
        <state>Kelantan</state>
        <zip>15200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Zulkiflee Salahuddin, MD MS</last_name>
    </contact>
    <investigator>
      <last_name>Zulkiflee Salahuddin, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosdi Ramli, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mahiran Mustafa, MBBCh MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anilawati Mat Jelani, MD MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Tuanku Jaafar</name>
      <address>
        <city>Seremban</city>
        <state>Negeri Sembilan</state>
        <zip>70300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Jeyasakthy Saniasiaya, MMed FEBORL</last_name>
    </contact>
    <investigator>
      <last_name>Jeyasakthy Saniasiaya, MMed FEBORL</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tiang Koi Ng, MBBS MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Tengku Ampuan Afzan</name>
      <address>
        <city>Kuantan</city>
        <state>Pahang</state>
        <zip>25100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Suhaimi Yusuf, MBBS MMed</last_name>
    </contact>
    <investigator>
      <last_name>Suhaimi Yusof, MBBS MMed</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dzawani Muhamad, MD MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Penang Hospital</name>
      <address>
        <city>George Town</city>
        <state>Penang</state>
        <zip>10990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Chenthilnathan Periasamy, MBBS MMed</last_name>
    </contact>
    <investigator>
      <last_name>Chenthilnathan Periasamy, MBBS MMed</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ting Soo Chow, MD MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Raja Permaisuri Bainun</name>
      <address>
        <city>Ipoh</city>
        <state>Perak</state>
        <zip>30450</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Philip Rajan Devesahayam, MMed FRCS</last_name>
    </contact>
    <investigator>
      <last_name>Philip Rajan Devesahayam, MMed FRCS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Tuanku Fauziah</name>
      <address>
        <city>Kangar</city>
        <state>Perlis</state>
        <zip>01000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Mohd Zambri Ibrahim, MD MMed</last_name>
    </contact>
    <investigator>
      <last_name>Mohd Zambri Ibrahim, MD MMed</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Suhaila Abd Wahab, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Queen Elizabeth</name>
      <address>
        <city>Kota Kinabalu</city>
        <state>Sabah</state>
        <zip>88200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Halimuddin Sawali, MBBS MS</last_name>
    </contact>
    <investigator>
      <last_name>Halimuddin Sawali, MBBS MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heng Gee Lee, MBChB MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sarawak General Hospital</name>
      <address>
        <city>Kuching</city>
        <state>Sarawak</state>
        <zip>93586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Chun Yiing Wong, MBBS MMed</last_name>
    </contact>
    <investigator>
      <last_name>Chun Yiing Wong, MBBS MMed</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sungai Buloh</name>
      <address>
        <city>Sungai Buloh</city>
        <state>Selangor</state>
        <zip>47000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Sobani Din, MD MS</last_name>
    </contact>
    <investigator>
      <last_name>Sobani Din, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fadzilah Ismail, MD MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kuldip Kaur Prem Kaur, MBBS MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Sultanah Nur Zahirah</name>
      <address>
        <city>Kuala Terengganu</city>
        <state>Terengganu</state>
        <zip>20400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Amran Mohamad, MD MS</last_name>
    </contact>
    <investigator>
      <last_name>Amran Mohamad, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mohd Noor Ismail, MD MRCP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kuala Lumpur General Hospital</name>
      <address>
        <city>Kuala Lumpur</city>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Elang Kumaran Krishnan, MBBS MS</last_name>
    </contact>
    <investigator>
      <last_name>Elang Kumaran Krishnan, MBBS MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chee Loon Leong, MBBS MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Melaka</name>
      <address>
        <city>Melaka</city>
        <zip>75400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <contact>
      <last_name>Linda Pei Fang Lim, MD MS</last_name>
    </contact>
    <investigator>
      <last_name>Linda Pei Fang Lim, MD MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nor Zaila Zaidan, MD MMed</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <link>
    <url>https://www.entnet.org/content/aao-hns-anosmia-hyposmia-and-dysgeusia-symptoms-coronavirus-disease</url>
    <description>AAO-HNS: Anosmia, Hyposmia, and Dysgeusia Symptoms of Coronavirus Disease | American Academy of Otolaryngology-Head and Neck Surgery</description>
  </link>
  <reference>
    <citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24. Erratum in: Lancet. 2020 Jan 30;:.</citation>
    <PMID>31986264</PMID>
  </reference>
  <reference>
    <citation>Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, Rusconi S, Gervasoni C, Ridolfo AL, Rizzardini G, Antinori S, Galli M. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.</citation>
    <PMID>32215618</PMID>
  </reference>
  <reference>
    <citation>Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.</citation>
    <PMID>32275288</PMID>
  </reference>
  <reference>
    <citation>Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, Dequanter D, Blecic S, El Afia F, Distinguin L, Chekkoury-Idrissi Y, Hans S, Delgado IL, Calvo-Henriquez C, Lavigne P, Falanga C, Barillari MR, Cammaroto G, Khalife M, Leich P, Souchay C, Rossi C, Journe F, Hsieh J, Edjlali M, Carlier R, Ris L, Lovato A, De Filippis C, Coppee F, Fakhry N, Ayad T, Saussez S. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.</citation>
    <PMID>32253535</PMID>
  </reference>
  <reference>
    <citation>Kaye R, Chang CWD, Kazahaya K, Brereton J, Denneny JC 3rd. COVID-19 Anosmia Reporting Tool: Initial Findings. Otolaryngol Head Neck Surg. 2020 Jul;163(1):132-134. doi: 10.1177/0194599820922992. Epub 2020 Apr 28. Review.</citation>
    <PMID>32340555</PMID>
  </reference>
  <reference>
    <citation>Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol. 2020 Jul;10(7):806-813. doi: 10.1002/alr.22579. Epub 2020 Jun 1.</citation>
    <PMID>32279441</PMID>
  </reference>
  <reference>
    <citation>Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, Boscolo-Rizzo P. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020 May 26;323(20):2089-2090. doi: 10.1001/jama.2020.6771.</citation>
    <PMID>32320008</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 10, 2020</study_first_submitted>
  <study_first_submitted_qc>May 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2020</study_first_posted>
  <last_update_submitted>May 12, 2020</last_update_submitted>
  <last_update_submitted_qc>May 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Sultanah Bahiyah</investigator_affiliation>
    <investigator_full_name>Siti Sabzah bt Mohd Hashim, MD, MS (ORL-HNS)</investigator_full_name>
    <investigator_title>Head of Otorhinolaryngology Service, Ministry of Health, Malaysia &amp; Senior Consultant Otorhinolaryngologist</investigator_title>
  </responsible_party>
  <keyword>Cross-sectional study</keyword>
  <keyword>Prevalence</keyword>
  <keyword>Otorhinolaryngology</keyword>
  <keyword>Infectious Diseases</keyword>
  <keyword>Anosmia</keyword>
  <keyword>Dysgeusia</keyword>
  <keyword>Olfactory Disorders</keyword>
  <keyword>Taste Disorders</keyword>
  <keyword>COVID-19</keyword>
  <keyword>SARS-CoV-2</keyword>
  <keyword>Coronavirus 2019</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Olfaction Disorders</mesh_term>
    <mesh_term>Dysgeusia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

